Search International and National Patent Collections
Some content of this application is unavailable at the moment.
If this situation persists, please contact us atFeedback&Contact
1. (WO1997018322) METHOD OF QUANTIFYING TUMOUR CELLS IN A BODY FLUID AND A SUITABLE TEST KIT
Latest bibliographic data on file with the International Bureau

Pub. No.: WO/1997/018322 International Application No.: PCT/DE1996/002183
Publication Date: 22.05.1997 International Filing Date: 14.11.1996
Chapter 2 Demand Filed: 27.05.1997
IPC:
C12Q 1/68 (2006.01)
C CHEMISTRY; METALLURGY
12
BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
Q
MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
1
Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions
68
involving nucleic acids
Applicants:
DAHM, Michael, W. [DE/DE]; DE
Inventors:
DAHM, Michael, W.; DE
Agent:
LEDERER, KELLER & RIEDERER; Prinzregentenstrasse 16 D-80538 München, DE
Priority Data:
195 42 795.516.11.1995DE
Title (DE) VERFAHREN ZUR QUANTIFIZIERUNG VON TUMORZELLEN IN EINER KÖRPERFLÜSSIGKEIT UND DAZU GEEIGNETE TESTKITS
(EN) METHOD OF QUANTIFYING TUMOUR CELLS IN A BODY FLUID AND A SUITABLE TEST KIT
(FR) PROCEDE POUR QUANTIFIER LE NOMBRE DE CELLULES CANCEREUSES DANS UN VOLUME HUMORAL ET NECESSAIRE D'ESSAI ADEQUAT
Abstract:
(DE) Offenbart wird ein Verfahren zur Quantifizierung von Tumorzellen in einer Körperflüssigkeit, bei dem zuerst mit der zu untersuchenden Probe eine Reaktion durchgeführt wird, bei der die RNA-Komponente der Telomerase spezifisch amplifiziert wird, und anschließend die Menge an amplifizierter Nukleinsäure quantitativ bestimmt wird sowie dazu geeignete Testkits.
(EN) The disclosure relates to a method of quantifying tumour cells in a body fluid. A reaction is first carried out with the sample under investigation by which the RNA component of the telomerase is specifically amplified. The quantity of amplified nucleic acid is then quantitatively determined. Also disclosed are suitable test kits.
(FR) L'invention concerne un procédé pour quantifier des cellules tumorales dans un volume humoral. Selon ce procédé, on commence à mettre en ÷uvre une réaction avec l'échantillon à examiner. Par cette réaction, la composante ARN de la télomérase est spécifiquement amplifiée. Ensuite, la quantité d'acide nucléique amplifiée est dénombrée. L'invention concerne également les nécessaires d'essai adéquats.
Designated States: AL, AM, AT, AU, AZ, BA, BB, BG, BR, BY, CA, CH, CN, CU, CZ, DE, DK, EE, ES, FI, GB, GE, HU, IL, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MD, MG, MK, MN, MW, MX, NO, NZ, PL, PT, RO, RU, SD, SE, SG, SI, SK, TJ, TM, TR, TT, UA, UG, US, UZ, VN
African Regional Intellectual Property Organization (ARIPO) (KE, LS, MW, SD, SZ, UG)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, CH, DE, DK, ES, FI, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, ML, MR, NE, SN, TD, TG)
Publication Language: German (DE)
Filing Language: German (DE)
Also published as:
EP0861334US20020012969JP2000512126 CN1202206CA2237589AU1997018673